|
JPS4927290B1
(cg-RX-API-DMAC7.html)
|
1969-08-05 |
1974-07-16 |
|
|
|
US4071618A
(en)
|
1974-09-03 |
1978-01-31 |
Research Foundation For Microbial Diseases Of Osaka University |
Process for preparing virus disease live vaccines
|
|
JPS57136528A
(en)
|
1981-02-09 |
1982-08-23 |
Hayashibara Biochem Lab Inc |
Preparation of viral vaccine
|
|
NZ219515A
(en)
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US5840520A
(en)
|
1989-08-28 |
1998-11-24 |
Aviron |
Recombinant negative strand RNA virus expression systems
|
|
US5786199A
(en)
|
1989-08-28 |
1998-07-28 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US5919676A
(en)
|
1993-06-24 |
1999-07-06 |
Advec, Inc. |
Adenoviral vector system comprising Cre-loxP recombination
|
|
JP3484215B2
(ja)
|
1994-01-27 |
2004-01-06 |
花王株式会社 |
チャイニーズハムスター卵巣細胞変異株
|
|
US5750394A
(en)
|
1994-05-20 |
1998-05-12 |
The Mount Sinai Medical Center |
Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
|
|
CA2149197A1
(en)
|
1994-06-17 |
1995-12-18 |
Irene Popiel |
Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture
|
|
DK0702085T4
(da)
|
1994-07-18 |
2010-04-06 |
Conzelmann Karl Klaus Prof Dr |
Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
|
|
EP0700991A1
(en)
|
1994-09-12 |
1996-03-13 |
Bayer Corporation |
Commercial scale concentrated preharvest tissue culture produced live T. Gondii bradyzoite and products and processes
|
|
WO1996010400A1
(en)
|
1994-09-30 |
1996-04-11 |
The Uab Research Foundation |
Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
|
|
EP0704533A1
(en)
|
1994-09-30 |
1996-04-03 |
Bayer Ag |
An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus
|
|
US5716821A
(en)
|
1994-09-30 |
1998-02-10 |
Uab Research Foundation |
Prevention and treatment of respiratory tract disease
|
|
AU3727895A
(en)
|
1994-09-30 |
1996-04-26 |
St. Jude Children's Research Hospital |
Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus
|
|
US6843996B1
(en)
|
1995-06-05 |
2005-01-18 |
Medimmune Vaccines, Inc. |
Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation
|
|
EP0780475B2
(en)
|
1995-08-09 |
2006-07-19 |
SCHWEIZ. SERUM- & IMPFINSTITUT BERN |
Process for the production of infectious negative-strand RNA viruses
|
|
US6037348A
(en)
|
1996-02-09 |
2000-03-14 |
Eli Lilly And Company |
Inhibition of viral replication
|
|
DE19612966B4
(de)
|
1996-04-01 |
2009-12-10 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
|
|
DE19612967A1
(de)
|
1996-04-01 |
1997-10-02 |
Behringwerke Ag |
Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
|
|
US5994526A
(en)
|
1996-06-21 |
1999-11-30 |
Plant Genetic Systems |
Gene expression in plants
|
|
EP0912724B1
(en)
|
1996-07-15 |
2009-12-09 |
The Government of The United States of America, as represented by The Department of Health and Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US6271011B1
(en)
|
1996-10-15 |
2001-08-07 |
The University Of Georgia Research Foundation, Inc. |
Pasteurella neuraminidase coding sequences and diagnostic methods
|
|
TW570803B
(en)
|
1997-04-09 |
2004-01-11 |
Duphar Int Res |
Influenza vaccine
|
|
WO1998048834A1
(en)
|
1997-04-30 |
1998-11-05 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
|
|
DE69842165D1
(de)
|
1997-05-23 |
2011-04-21 |
Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services |
Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen
|
|
EP0996717B1
(en)
|
1997-08-05 |
2005-12-07 |
Vlaams Interuniversitair Instituut voor Biotechnologie vzw. |
Immunoprotective influenza antigen and its use in vaccination
|
|
US6169175B1
(en)
|
1997-08-06 |
2001-01-02 |
Centers For Disease Control And Prevention |
Preparation and use of recombinant influenza A virus M2 construct vaccines
|
|
US20020010143A1
(en)
|
1997-09-26 |
2002-01-24 |
Miguel S. Barbosa |
Compositions and methods for the treatment of human cytomegalovirus infection
|
|
KR100281676B1
(ko)
|
1997-11-29 |
2001-04-02 |
신동권 |
신규한독감생백신바이러스
|
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
US6270958B1
(en)
|
1998-10-29 |
2001-08-07 |
Washington University |
Detection of negative-strand RNA viruses
|
|
CA2364934C
(fr)
|
1999-02-22 |
2011-10-18 |
Transgene S.A. |
Procede d'obtention d'une preparation virale purifiee
|
|
EP1035209A1
(en)
|
1999-03-06 |
2000-09-13 |
ARTEMIS Pharmaceuticals GmbH |
Stable recombinant influenza viruses free of helper viruses
|
|
DK1820853T3
(da)
|
1999-04-06 |
2011-12-19 |
Wisconsin Alumni Res Found |
Rekombinant influenzavirus til vacciner og genterapi
|
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
|
DE122007000070I1
(de)
|
1999-07-14 |
2008-01-31 |
Sinai School Medicine |
In Vitro-rekonstitution von segmentierten Negativstrang-Rna-Viren
|
|
AU7841400A
(en)
|
1999-10-01 |
2001-05-10 |
Genovo, Incorporated |
Production of recombinant aav using adenovirus comprising aav rep/cap genes
|
|
US6686168B1
(en)
|
1999-11-04 |
2004-02-03 |
Zymogenetics, Inc. |
Cell surface display of proteins by recombinant host cells
|
|
US7192759B1
(en)
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
AU782624B2
(en)
|
1999-12-30 |
2005-08-18 |
Board Of Trustees Of Miami University |
Methods and compositions for inhibiting adhesion by microorganisms
|
|
CA2401117C
(en)
|
2000-03-03 |
2010-06-29 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
|
|
AU5533601A
(en)
|
2000-04-14 |
2001-10-30 |
Wisconsin Alumni Res Found |
Viruses comprising mutation ion channel protein
|
|
AU5921101A
(en)
|
2000-04-28 |
2001-11-12 |
St Jude Childrens Res Hospital |
Dna transfection system for the generation of infectious influenza virus
|
|
US6358733B1
(en)
|
2000-05-19 |
2002-03-19 |
Apolife, Inc. |
Expression of heterologous multi-domain proteins in yeast
|
|
US20040241139A1
(en)
|
2000-07-20 |
2004-12-02 |
Gerd Hobom |
Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
EP1201760A1
(en)
|
2000-10-30 |
2002-05-02 |
ARTEMIS Pharmaceuticals GmbH |
Influenza virus vector for human dendritic cells
|
|
US7449188B2
(en)
|
2001-01-18 |
2008-11-11 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
Recombinant oligometric protein complexes with enhanced immunogenic potential
|
|
EP1233059A1
(en)
|
2001-02-09 |
2002-08-21 |
ARTEMIS Pharmaceuticals GmbH |
Influenza viruses with enhanced transcriptional and replicational capacities
|
|
EP1364006A2
(en)
|
2001-02-23 |
2003-11-26 |
Wisconsin Alumni Research Foundation |
Methods to identify mutant cells with altered sialic acid
|
|
DE10144906B4
(de)
|
2001-09-12 |
2013-11-28 |
Novartis Vaccines And Diagnostics Gmbh |
Verfahren zur großtechnischen Herstellung von Impfstoffen
|
|
CA2465895C
(en)
|
2001-11-07 |
2012-10-02 |
U.S. Army Medical Research Institute Of Infectious Diseases Department Of The Army |
Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
|
|
US7682618B2
(en)
|
2001-11-07 |
2010-03-23 |
The United States Of America As Represented By The Secretary Of The Army |
Generation of virus-like particles and use as panfilovirus vaccine
|
|
US6951752B2
(en)
|
2001-12-10 |
2005-10-04 |
Bexter Healthcare S.A. |
Method for large scale production of virus antigen
|
|
US7211378B2
(en)
|
2002-01-31 |
2007-05-01 |
Wisconsin Alumni Research Foundation |
Filovirus vectors and noninfectious filovirus-based particles
|
|
CN1997734A
(zh)
|
2002-02-13 |
2007-07-11 |
威斯康星旧生研究基金会 |
包装流感病毒载体的信号
|
|
EP3009507B1
(en)
|
2002-02-13 |
2020-06-24 |
Wisconsin Alumini Research Foundation |
Signal for packaging of influenza virus vectors
|
|
WO2003076462A1
(en)
|
2002-03-08 |
2003-09-18 |
Crucell Holland B.V. |
Use of recombinant trypsin for vaccine production
|
|
FR2837497A1
(fr)
|
2002-03-22 |
2003-09-26 |
Univ Nantes |
Procede de production de vecteurs lentiviraux a haut titre
|
|
CN1678345B
(zh)
|
2002-04-26 |
2013-09-11 |
米迪缪尼有限公司 |
制备流感病毒的多质粒系统
|
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
US20060088909A1
(en)
|
2002-05-17 |
2006-04-27 |
Compans Richard W |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
DK1520008T3
(da)
|
2002-07-09 |
2012-10-15 |
Baxter Int |
Medium frit for dyreprotein til dyrkning af celler
|
|
US6875433B2
(en)
|
2002-08-23 |
2005-04-05 |
The United States Of America As Represented By The Secretary Of The Army |
Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
|
|
US20040242518A1
(en)
|
2002-09-28 |
2004-12-02 |
Massachusetts Institute Of Technology |
Influenza therapeutic
|
|
US20040142322A1
(en)
|
2002-10-07 |
2004-07-22 |
Schering Corporation |
Continuous non-radioactive polymerase assay
|
|
JP2007525175A
(ja)
|
2003-04-23 |
2007-09-06 |
ウィスコンシン アルムニ リサーチ ファウンデイション |
突然変異した膜タンパク質をその機能性の一部ウイルス
|
|
AU2004274860A1
(en)
|
2003-05-28 |
2005-03-31 |
Wisconsin Alumni Research Foundation |
Recombinant influenza vectors with a polII promoter and ribozymes
|
|
ES2593082T3
(es)
|
2003-05-28 |
2016-12-05 |
Wisconsin Alumni Research Foundation |
Virus de la gripe recombinantes a título elevado para vacunas y terapia génica
|
|
EP1633312A4
(en)
|
2003-06-16 |
2012-09-26 |
Medimmune Llc |
INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US20060240515A1
(en)
|
2003-07-21 |
2006-10-26 |
Dimitrov Dimiter S |
Soluble fragments of the SARS-CoV spike glycoprotein
|
|
US7037707B2
(en)
|
2003-09-04 |
2006-05-02 |
St. Jude Children's Research Hospital |
Method for generating influenza viruses and vaccines
|
|
US7279275B2
(en)
|
2003-11-03 |
2007-10-09 |
Washington University |
Methods and compositions for detection of segmented negative strand RNA viruses
|
|
EP1697521B1
(en)
|
2003-12-23 |
2010-06-02 |
MedImmune, LLC |
Multi plasmid system for the production of influenza virus
|
|
JP2005245302A
(ja)
|
2004-03-04 |
2005-09-15 |
Kanazawa Univ Tlo Inc |
組換えインフルエンザウイルスおよびそれを用いたワクチン
|
|
US20060099609A1
(en)
|
2004-04-13 |
2006-05-11 |
Sina Bavari |
Activation of natural killer (NK) cells and methods of use
|
|
AU2005245943A1
(en)
|
2004-05-20 |
2005-12-01 |
Id Biomedical Corporation |
Process for the production of an influenza vaccine
|
|
RS51665B
(sr)
|
2004-09-09 |
2011-10-31 |
Novartis Vaccines And Diagnostics Gmbh. |
Smanjenje potencijalnih jatrogenih rizika povezanih sa vakcinama protiv gripa
|
|
KR20070100882A
(ko)
|
2004-11-11 |
2007-10-12 |
솔베이 파마슈티칼스 비. 브이 |
결손 인플루엔자 바이러스 입자
|
|
CN101103103A
(zh)
|
2004-11-19 |
2008-01-09 |
威斯康星旧生研究基金会 |
具有串联转录单位的重组流感病毒载体
|
|
ES2526170T3
(es)
|
2004-12-23 |
2015-01-07 |
Medimmune, Llc |
Línea celular MDCK no tumorigénica para propagar virus
|
|
NZ556061A
(en)
|
2004-12-24 |
2009-06-26 |
Solvay Biologicals Bv |
Rescue of influenza virus
|
|
ES2527503T3
(es)
|
2005-03-08 |
2015-01-26 |
Medimmune, Llc |
Virus influenza reordenantes
|
|
KR20080052509A
(ko)
|
2005-04-11 |
2008-06-11 |
더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션 |
유행성 독감 바이러스에 대한 백신
|
|
FR2887958B1
(fr)
|
2005-07-01 |
2007-10-12 |
Prospection Et D Inv S Techniq |
Dispositif de reglage de commande de vanne pour appareil de fixation a gaz et l'appareil comportant le dispositif
|
|
NL1030161C2
(nl)
|
2005-10-11 |
2007-04-12 |
Matthijs Dirk Meulenbelt |
Presentatie-inrichting.
|
|
ES2402061T3
(es)
|
2005-10-17 |
2013-04-26 |
Medimmune, Llc |
Método de aumento de la replicación del virus influenza
|
|
PL2478916T3
(pl)
|
2006-01-27 |
2020-11-16 |
Seqirus UK Limited |
Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy
|
|
AU2012204138B2
(en)
|
2006-03-31 |
2014-02-06 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
AU2014202470B2
(en)
|
2006-03-31 |
2016-08-04 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
JP2009532352A
(ja)
|
2006-03-31 |
2009-09-10 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
ワクチンのための高力価組み換えインフルエンザ・ウィルス
|
|
EP2022849A4
(en)
|
2006-05-11 |
2010-10-06 |
Chemo Sero Therapeut Res Inst |
PROCESS FOR THE PROLIFERATION OF INFLUENZA VIRUS
|
|
US20090017444A1
(en)
|
2006-06-09 |
2009-01-15 |
Wisconsin Alumni Research Foundation |
Screening method for modulators of viral transcription or replication
|
|
US7507411B2
(en)
|
2006-06-23 |
2009-03-24 |
University Of Saskatchewan |
Attenuated influenza NS1 variants
|
|
WO2008133701A1
(en)
|
2006-07-21 |
2008-11-06 |
Medimmune, Llc. |
Methods and compositions for increasing replication capacity of an influenza virus
|
|
CA2659267C
(en)
|
2006-08-09 |
2016-12-13 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
|
AU2007347716B2
(en)
|
2006-09-15 |
2013-06-20 |
Medimmune, Llc |
MDCK cell lines supporting viral growth to high titers and bioreactor process using the same
|
|
JP2011506264A
(ja)
|
2006-12-06 |
2011-03-03 |
ノバルティス アーゲー |
インフルエンザウイルスの4つの株に由来する抗原を含むワクチン
|
|
US8465960B2
(en)
|
2007-03-28 |
2013-06-18 |
Wisconsin Alumni Research Foundation |
Influenza B viruses with reduced sensitivity to neuraminidase inhibitors
|
|
EP2137511B1
(en)
*
|
2007-04-16 |
2019-01-02 |
BAE Systems PLC |
Corrosion sensors
|
|
WO2008147496A2
(en)
|
2007-05-04 |
2008-12-04 |
Warf - Wisconsin Alumni Research Foundation |
Neuraminidase-deficient live influenza vaccines
|
|
US8043856B2
(en)
|
2007-06-14 |
2011-10-25 |
Wisconsin Alumni Research Foundation |
Adenoviral vectors for influenza virus production
|
|
US9474798B2
(en)
|
2007-06-18 |
2016-10-25 |
Wisconsin Alumni Research Foundation |
Influenza M2 protein mutant viruses as live influenza attenuated vaccines
|
|
CA2690196A1
(en)
|
2007-06-18 |
2008-12-24 |
Medimmune, Llc |
Influenza b viruses having alterations in the hemaglutinin polypeptide
|
|
WO2008155681A1
(en)
|
2007-06-21 |
2008-12-24 |
Nds Limited |
Power saving device
|
|
EP2048237A1
(en)
|
2007-10-05 |
2009-04-15 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Replication deficient Influenza virus for the expression of heterologous sequences
|
|
PT2185191E
(pt)
|
2007-06-27 |
2012-11-27 |
Novartis Ag |
Vacinas contra a gripe com baixo teor de aditivos
|
|
WO2009014919A2
(en)
|
2007-07-13 |
2009-01-29 |
Iowa State University Research Foundation, Inc. |
H2n3 influenza a viruses and methods of use
|
|
WO2009049350A1
(en)
|
2007-10-15 |
2009-04-23 |
The University Of Queensland |
Expression system for modulating an immune response
|
|
WO2009128867A2
(en)
|
2008-01-07 |
2009-10-22 |
Warf - Wisconsin Alumni Research Foundation |
Recombinant biologically contained filovirus
|
|
EP2296701A1
(en)
|
2008-06-11 |
2011-03-23 |
Flugen, Inc. |
Cell-based systems for producing influenza vaccines
|
|
US8591914B2
(en)
|
2008-07-11 |
2013-11-26 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
|
JP5852883B2
(ja)
|
2008-08-08 |
2016-02-03 |
タケダ ワクチン,インコーポレイテッド |
交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
|
|
WO2010053573A2
(en)
|
2008-11-07 |
2010-05-14 |
Yoshihiro Kawaoka |
Screen for inhibitors of filovirus and uses therefor
|
|
HRP20140597T1
(hr)
|
2009-07-16 |
2014-09-12 |
Crucell Holland B.V. |
Proizvodnja polio virusa u visokim titrima za proizvodnju cjepiva
|
|
US9217157B2
(en)
|
2009-07-27 |
2015-12-22 |
Icahn School Of Medicine At Mount Sinai |
Recombinant influenza viruses and uses thereof
|
|
US8828406B2
(en)
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
|
US8507247B2
(en)
|
2009-08-11 |
2013-08-13 |
Wisconsin Alumni Research Foundation |
Influenza A virus with attenuating mutations in NS2 protein
|
|
JP2013507990A
(ja)
|
2009-10-26 |
2013-03-07 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
|
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
KR101740019B1
(ko)
|
2009-11-10 |
2017-05-26 |
주식회사 팬택 |
무선통신시스템에서 시스템 정보 송수신 방법 및 그를 이용한 시스템 정보 송신장치와 수신장치
|
|
AU2010321710B2
(en)
|
2009-11-23 |
2013-03-07 |
Wm. Wrigley Jr. Company |
Gum bases, chewing gums based thereupon, and methods for making the same
|
|
WO2011087839A1
(en)
*
|
2009-12-22 |
2011-07-21 |
Baxter International Inc. |
Vaccine to influenza a virus
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
US20130034578A1
(en)
|
2010-04-09 |
2013-02-07 |
Petrus Josephus Marie Rottier |
Recombinant multimeric influenza proteins
|
|
WO2011130627A2
(en)
|
2010-04-16 |
2011-10-20 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Chimpanzee adenoviral vector-based filovirus vaccines
|
|
GB201011502D0
(en)
|
2010-07-08 |
2010-08-25 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
WO2012033236A1
(ko)
|
2010-09-06 |
2012-03-15 |
에스케이케미칼 주식회사 |
무혈청 배양 및 부유 배양에 적응된 mdck 세포주 및 상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
|
|
WO2012045882A2
(en)
|
2010-10-07 |
2012-04-12 |
Ac Immune S.A. |
Pharmaceutical composition
|
|
MX2013006234A
(es)
|
2011-01-06 |
2013-08-01 |
Univ Johns Hopkins |
Metodo para la produccion de glicoproteinas recombinantes con semivida en circulacion incrementada en celulas de mamifero.
|
|
CN106995802B
(zh)
|
2011-06-24 |
2021-04-09 |
复尔健有限公司 |
流感病毒突变体及其用途
|
|
ES2655051T3
(es)
|
2011-08-26 |
2018-02-16 |
Wisconsin Alumni Research Foundation |
Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas
|
|
CN102304495A
(zh)
|
2011-09-08 |
2012-01-04 |
中国农业科学院上海兽医研究所 |
高效表达ha蛋白的重组流感病毒及其制备方法和应用
|
|
WO2013087945A2
(en)
|
2012-03-02 |
2013-06-20 |
Novartis Ag |
Influenza virus reassortment
|
|
JP2015527296A
(ja)
|
2012-03-26 |
2015-09-17 |
アメリカ合衆国 |
哺乳動物細胞へのパッケージングされたrnaの新規の送達
|
|
EA201590860A1
(ru)
|
2012-11-16 |
2015-11-30 |
МЕДИММЬЮН, ЭлЭлСи |
Варианты гемагглютинина и нейраминидазы вируса свиного гриппа
|
|
MX374811B
(es)
|
2013-03-15 |
2025-03-06 |
Ac Immune Sa |
Anticuerpos anti-tau y métodos de uso.
|
|
CN105722976A
(zh)
|
2013-06-06 |
2016-06-29 |
诺华股份有限公司 |
流感病毒重配
|
|
JP2016524915A
(ja)
|
2013-07-15 |
2016-08-22 |
ウィスコンシン アルムニ リサーチ ファンデイション |
Mdck、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス
|
|
SG10201807208RA
(en)
|
2014-03-04 |
2018-09-27 |
Sigma Aldrich Co Llc |
Viral resistant cells and uses thereof
|
|
US9757446B2
(en)
|
2014-03-17 |
2017-09-12 |
Flugen, Inc. |
Influenza virus vectors and uses therefor
|
|
US10053671B2
(en)
|
2014-06-20 |
2018-08-21 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
CA2959105C
(en)
|
2014-09-03 |
2023-10-17 |
Bavarian Nordic A/S |
Recombinant modified vaccinia virus ankara (mva) filovirus vaccine
|
|
WO2016054598A2
(en)
|
2014-10-03 |
2016-04-07 |
Massachusetts Institute Of Technology |
Antibodies that bind ebola glycoprotein and uses thereof
|
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
|
US10429386B2
(en)
|
2015-03-10 |
2019-10-01 |
The Regents Of The University Of California |
Antibodies to the surface of Toxoplasma gondii oocysts and methods of use thereof
|
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
|
KR20180035807A
(ko)
*
|
2015-06-26 |
2018-04-06 |
세퀴러스 유케이 리미티드 |
항원적으로 매치된 인플루엔자 백신
|
|
WO2017007839A1
(en)
|
2015-07-06 |
2017-01-12 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza virus replication for vaccine development
|
|
US20170121391A1
(en)
|
2015-07-07 |
2017-05-04 |
Wisconsin Alumni Research Foundation (Warf) |
Potent glycoprotein antibody as a therapeutic against ebola virus
|
|
WO2017040203A1
(en)
|
2015-08-28 |
2017-03-09 |
Yoshihiro Kawaoka |
Generation of infectious influenza viruses from virus-like particles
|
|
CN105296356A
(zh)
|
2015-12-02 |
2016-02-03 |
河南农业大学 |
一种刚地弓形虫卵囊的制备、纯化及保存方法
|
|
US10063211B2
(en)
|
2016-02-03 |
2018-08-28 |
Qualcomm Incorporated |
Compact bypass and decoupling structure for millimeter-wave circuits
|
|
JP2019510481A
(ja)
|
2016-02-19 |
2019-04-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ワクチン開発のための改善されたb型インフルエンザウイルス複製
|
|
JP2018064493A
(ja)
|
2016-10-19 |
2018-04-26 |
京都府公立大学法人 |
Mdck細胞を用いたインフルエンザウイルスの増殖方法
|
|
WO2019084310A1
(en)
|
2017-10-25 |
2019-05-02 |
Yoshihiro Kawaoka |
HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
|
|
WO2019241579A1
(en)
|
2018-06-13 |
2019-12-19 |
Wisconsin Alumni Research Foundation |
Toxoplasma gondii vaccine
|
|
US12343390B2
(en)
|
2018-08-07 |
2025-07-01 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant biologically contained filovirus vaccine
|
|
US11389523B2
(en)
|
2018-08-20 |
2022-07-19 |
Wisconsin Alumni Research Foundation (Warf) |
Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
|
|
US12064478B2
(en)
|
2018-09-21 |
2024-08-20 |
Nutech Ventures |
Methods of making and using universal centralized influenza vaccine genes
|
|
EP3914295A2
(en)
|
2019-01-23 |
2021-12-01 |
Yoshihiro Kawaoka |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
WO2020163804A1
(en)
|
2019-02-08 |
2020-08-13 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
|
US20220249652A1
(en)
|
2019-06-26 |
2022-08-11 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus neuraminidase and uses thereof
|
|
WO2021041624A2
(en)
|
2019-08-27 |
2021-03-04 |
Yoshihiro Kawaoka |
Recombinant influenza viruses with stabilized ha for replication in eggs
|
|
JP2023511444A
(ja)
|
2020-01-24 |
2023-03-17 |
ウィスコンシン アルムニ リサーチ ファンデイション |
安定化されたnaを有する組換えインフルエンザウイルス
|
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
|
WO2021195410A1
(en)
|
2020-03-25 |
2021-09-30 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
WO2021242597A1
(en)
|
2020-05-23 |
2021-12-02 |
Wisconsin Alumni Research Foundation ("Warf") |
Ace2 expressing influenza virus
|
|
WO2022245888A1
(en)
|
2021-05-19 |
2022-11-24 |
Modernatx, Inc. |
Seasonal flu rna vaccines and methods of use
|
|
US20230321217A1
(en)
|
2021-09-28 |
2023-10-12 |
Yoshihiro Kawaoka |
Compositions comprising complexes displaying antigens and methods of using the compositions
|
|
WO2023125889A1
(en)
|
2021-12-31 |
2023-07-06 |
Suzhou Abogen Biosciences Co., Ltd. |
Quadrivalent mrna vaccines for influenza viruses
|
|
WO2023164556A2
(en)
|
2022-02-23 |
2023-08-31 |
Wisconsin Alumni Research Foundation |
Broadly protective influenza b virus vaccines
|
|
WO2024015510A1
(en)
|
2022-07-13 |
2024-01-18 |
Wisconsin Alumni Research Foundation ("Warf") |
Sars-cov-2 lacking the envelope protein as an attenuated vaccine virus against covid-19
|
|
US20240238403A1
(en)
|
2022-11-16 |
2024-07-18 |
Wisconsin Alumni Research Foundation |
Influenza virus replication for vaccine development
|
|
US20260226425A1
(en)
|
2023-03-21 |
2026-08-06 |
The University Of Tokyo |
Cold-adapted, live attenuated sars-cov-2 vaccine
|